Triethylamine → HCID 86690718, compound
Reaction equation
[O:1]=[C:2]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4](P(=O)(OC)OC)[O:3]1.[N:17]1[CH:18]=[CH:19][N:20]2[CH:25]=[CH:24][CH:23]=[C:22]([CH:26]=O)[C:21]=12.CCN(CC)CC>C1COCC1>[N:17]1[CH:18]=[CH:19][N:20]2[CH:25]=[CH:24][CH:23]=[C:22]([CH:26]=[C:4]3[C:5]4[C:10](=[CH:9][CH:8]=[CH:7][CH:6]=4)[C:2](=[O:1])[O:3]3)[C:21]=12Participants
Procedure
To a solution of dimethyl 3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonate (610 mg, 2.4 mmol), imidazo[1,2-a]pyridine-8-carbaldehyde (350 mg, 2.4 mmol, 1 equiv.) in THF (5 mL) was added Et3N (0.33 mL 2.4 mmol). The mixture was stirred at rt for 48 h. The precipitation was filtered off and washed with EtOAc. The filtrate was concentrated to give 3-(imidazo[1,2-a]pyridin-8-ylmethylene)isobenzofuran-1(3H)-one (400 mg, 64%) as a yellow solid. Small crude sample (˜20 mg) was purified on RP-HPLC with CH3CN and water as eluent to separated the E/Z isomers (10 mg, 7 mg). 1H NMR (400 MHz, CD3OD) Z-form: δ=8.52 (d, 1H), 7.95-7.91 (m, 2H), 7.62-7.54 (m, 4H), 7.52-7.48 (m, 1H), 7.09 (s, 1H), 7.04 (t, 1H) E-form: δ=8.38 (d, 1H), 8.15 (d, H), 8.05 (d, 1H), 7.95 (d, 1H), 7.90-7.84 (m, 2H), 7.67 (t, 1H), 7.64 (s, 1H), 7.33 (s, 1H), δ 7.05 (t, 1H). LRMS (M+H+) m/z 263.1
Workup
- customThe precipitation
- filtrationwas filtered off
- washwashed with EtOAc
- concentrationThe filtrate was concentrated
Sources & evidence
- ORD record
- ord-fc94cc3da1cf45e68fcbcb19bc6493d1
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09018210B2
Reaction notes
Loading…